Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Whitehawk Therapeutics, Inc. (WHWK) had Revenue of $25.98M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$25.98M
Net Income	$-63.69M
Cost of Goods Sold	$3.02M
Gross Profit	$22.96M
Operating Expenses	$93.44M
Operating Income	$-67.46M
Non-Operating Income/Expense	$3.77M
Pre-Tax Income	$-63.69M
Normalized Pre-Tax Income	$-63.69M
Income after Taxes	$-63.69M
Income from Continuous Operations	$-63.69M
Consolidated Net Income/Loss	$-63.69M
Normalized Income after Taxes	$-63.69M
EBIT	$-67.46M
EBITDA	$-68.57M
Weighted-Average Shares Outstanding (Basic)	27.03M
Weighted-Average Shares Outstanding (Diluted)	27.03M
Earnings per Share (EPS) (Basic)	$-2.36
Earnings per Share (EPS) (Diluted)	$-2.36
Balance Sheet Financials
Current Assets	$61.29M
Property, Plant, and Equipment	$6.85M
Long-Term Assets	$9.03M
Total Assets	$70.32M
Current Liabilities	$17.07M
Long-Term Debt	--
Long-Term Liabilities	$0.77M
Total Liabilities	$17.84M
Common Equity	$52.48M
Tangible Shareholders Equity	$52.48M
Shareholders Equity	$52.48M
Common Shares Outstanding	24.68M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-59.55M
Cash Flow from Investing Activities	$25.20M
Cash Flow from Financial Activities	$0.13M
Beginning Cash	$62.95M
End Cash	$28.73M
Increase/Decrease in Cash	$-34.22M
Stock-Based Compensation	$10.84M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.59
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	88.36%
Operating Margin	-259.62%
EBIT Margin	-259.62%
EBITDA Margin	-263.89%
Pre-Tax Profit Margin	-245.13%
Profit Margin	-245.13%
Free Cash Flow	$-61.20M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.37
Inventory Turnover	0.57
Receiveable Turnover	4.40
Days Sales in Receivables	82.92
Return on Equity	-121.37%
Return on Tangible Equity	-121.37%
Return on Assets	-90.57%
Return on Investments	-121.37%
Book Value Per Share	$2.13
Free Cash Flow per Share	$-2.26
Operating Cash Flow per Share	$-2.20

Data from Zacks Investment Research, Inc.